Acroscell is a global leading provider of quality services in research and development including cardiac & neuronal safety profiling and translational assays for the academia, pharmaceutical, and biotechnology industries. We offer an innovative, time-efficient, cost-effective and comprehensive range of preclinical R&D services specialized in but not limited to cardiovascular & neural system physiological/pathophysiological mechanisms with strong scientific support.
As a service company with strong strength in the field of electrophysiological techniques, we focused on both in vivo and in vitro assays. Thanks to our cutting-edge electrophysiological screening platform, a diverse portfolio of standard and customized drug safety & pharmacology assays and panels for drug screening and profiling are available in Acroscell. Our teams have broad drug discovery capabilities, expertise and proven experience in meeting a wide variety of project objectives successfully with respect to the delivery of quality data and on-time performance. We understand that the time-cost is a major concern in drug discovery. To reduce this, our broad global service capabilities, and decades of experience in providing drug discovery services, resulting in the delivery of high quality, reproducible study performance with few repeats and high client satisfaction.
